Mundipharma’s rezafungin cleared by MHRA for invasive candidiasis in Great Britain

In a significant advancement for antifungal therapy, Napp Pharmaceuticals Limited, a key player within the international network of Mundipharma independent associated companies, has announced the ... Read More